Insights from computational modeling in inflammation and acute rejection in limb transplantation

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Wolfram, Dolores ^a   Starzl, Ravi ^b   Hackl, Hubert ^a   Barclay, Derek ^c   Hautz, Theresa ^a   Zelger, Bettina ^d   Brandacher, Gerald ^e   Lee, W P Andrew ^e   Eberhart, Nadine ^a   Vodovotz, Yoram ^c   Pratschke, Johann ^a   Pierer, Gerhard ^a   Schneeberger, Stefan ^a,e  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Language Technologies Institute Carnegie Mellon University ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12P70; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN GRO KC; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ACUTE MUSCLE REJECTION; ACUTE SKIN REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPOSITE GRAFT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG TARGETING; DYSKERATOSIS; EARLY DIAGNOSIS; HIERARCHICAL CLUSTERING ANALYSIS; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY INFILTRATE; ISOGRAFT; LEUKOCYTE; LIMB TRANSPLANTATION; MALE; MULTINOMIAL LOGISTIC REGRESSION ANALYSIS; MUSCLE BIOPSY; NONHUMAN; POSTOPERATIVE COMPLICATION; PREDICTION; PRINCIPAL COMPONENT ANALYSIS; RANDOM FOREST; RAT; SKIN ALLOGRAFT; SKIN BIOPSY; STATISTICAL ANALYSIS; STATISTICAL MODEL; TISSUE SPECIFICITY; TRANSPLANTATION; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; ALLOTRANSPLANTATION; ANIMAL; COMPUTER SIMULATION; DRUG EFFECTS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; LIMB; METABOLISM; SKIN;

ANIMALS; COMPUTER SIMULATION; EXTREMITIES; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; MALE; RATS; SKIN; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902774338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099926     Document Type: Article

References (43)

1. Cendales LC, Kanitakis J, Schneeberger S, Burns C, Ruiz P, et al. (2008) The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 8: 1396-1400. (Pubitemid 351989486)
2. Kanitakis J, Jullien D, Nicolas JF, Frances C, Claudy A, et al. (2000) Sequential histological and immunohistochemical study of the skin of the first human hand allograft. Transplantation 69: 1380-1385. (Pubitemid 30238728)
3. Kanitakis J (2008) The challenge of dermatopathological diagnosis of composite tissue allograft rejection: a review. J Cutan Pathol 35: 738-744.
4. Schneeberger S, Gorantla VS, van Riet RP, Lanzetta M, Vereecken P, et al. (2008) Atypical acute rejection after hand transplantation. Am J Transplant 8:688-696. (Pubitemid 351287537)
5. Hautz T, Wolfram D, Grahammer J, Starzl R, Krapf C, et al. (2012) Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation. Clin Dev Immunol: 1-9.
6. Tarca AL, Carey VJ, Chen XW, Romero R, Draghici S (2007) Machine learning and its applications to biology. PLoS Comput Biol 3: e116.
7. Coin L, Bateman A, Durbin R (2003) Enhanced protein domain discovery by using language modeling techniques from speech recognition. Proc Natl Acad Sci U S A 100: 4516-4520. (Pubitemid 36457762)
8. Hautz T, Zelger B, Grahammer J, Krapf C, Amberger A, et al. (2010) Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation. Am J Transplant 10: 1200-1209.
9. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
10. Sturn A, Quackenbush J, Trajanoski Z (2002) Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208. (Pubitemid 34145055)
11. Breiman L (2001) Random Forests. Machine Learning 45: 5-32.
12. Mi Q, Constantine G, Ziraldo C, Solovyev A, Torres A, et al. (2011) A dynamic view of trauma/hemorrhage-induced inflammation in mice: principal drivers and networks. PLoS One 6: e19424.
13. Namas RA, Namas R, Lagoa C, Barclay D, Mi Q, et al. (2012) Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies. Mol Med 18: 1366-1374.
14. Page EK, Dar WA, Knechtle SJ (2012) Biologics in organ transplantation. Transpl Int 25: 707-719.
15. Sarwal MM (2006) Chipping into the human genome: novel insights for transplantation. Immunol Rev 210: 138-155.
16. Vodovotz Y (2006) Deciphering the complexity of acute inflammation using mathematical models. Immunol Res 36: 237-245.
17. Mesarovic MD, Sreenath SN, Keene JD (2004) Search for organising principles: understanding in systems biology. Syst Biol (Stevenage) 1: 19-27.
18. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037. (Pubitemid 41486985)
19. Warren HS, Elson CM, Hayden DL, Schoenfeld DA, Cobb JP, et al. (2009) A genomic score prognostic of outcome in trauma patients. Mol Med 15: 220-227.
20. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, et al. (2005) The acute inflammatory response in diverse shock states. Shock 24: 74-84. (Pubitemid 40946598)
21. Bohra R, Klepacki J, Klawitter J, Thurman JM, Christians U (2013) Proteomics and metabolomics in renal transplantation-quo vadis? Transpl Int 26: 225-241.
22. Azhar N (2013) Analysis of serum inflammatory mediators identifies unique dynamic networks associated with death and spontaneous survival in pediatric acute liver failure.
23. Grenz A, Schenk M, Zipfel A, Viebahn R (2000) TNF-alpha and its receptors mediate graft rejection and loss after liver transplantation. Clin Chem Lab Med 38: 1183-1185. (Pubitemid 32040867)
24. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF (1991) Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 88: 4220- 4224.
25. Imagawa DK, Millis JM, Olthoff KM, Derus LJ, Chia D, et al. (1990) The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation 50: 219-225. (Pubitemid 20259164)
26. Bubnova LN, Kabakov A, Serebrianaya N, Ketlinky S (1992) Interleukin-1 beta and tumor necrosis factor-alpha serum levels in renal allograft recipients. Transplant Proc 24: 2545. (Pubitemid 23011589)
27. Grewal HP, Kotb M, Salem A, el Din AB, Novak K, et al. (1993) Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection. Transplant Proc 25: 132-135. (Pubitemid 23082304)
28. Goriely S, Goldman M (2008) Interleukin-12 family members and the balance between rejection and tolerance. Curr Opin Organ Transplant 13: 4-9.
29. Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, et al. (1996) IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol 157: 1951-1957. (Pubitemid 126449668)
30. Verma ND, Boyd R, Robinson C, Plain KM, Tran GT, et al. (2006) Interleukin- 12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production. Transplantation 82: 1324-1333. (Pubitemid 44832916)
31. Dey BR, Yang YG, Szot GL, Pearson DA, Sykes M (1998) Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood 91: 3315-3322. (Pubitemid 28193882)
32. Nathan C, Sporn M (1991) Cytokines in context. J Cell Biol 113: 981-986. (Pubitemid 21909731)
33. Dinarello CA (1999) IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103: 11-24.
34. Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, et al. (2009) The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol 183: 4705-4714.
35. Rider P, Carmi Y, Guttman O, Braiman A, Cohen I, et al. (2011) IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation. J Immunol 187: 4835-4843.
36. van de Veerdonk FL, Netea MG (2013) New Insights in the Immunobiology of IL-1 Family Members. Front Immunol 4: 167.
37. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550.
38. Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341: 1817-1828.
39. Schon MP, Ludwig RJ (2005) Lymphocyte trafficking to inflamed skin - molecular mechanisms and implications for therapeutic target molecules. Expert Opin Ther Targets 9: 225-243. (Pubitemid 40613865)
40. Yuan J, Liu Y, Huang W, Zhou S, Ling S, et al. (2013) The experimental treatment of corneal graft rejection with the interleukin-1 receptor antagonist (IL-1ra) gene. PLoS One 8: e60714.
41. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, et al. (1999) Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136. (Pubitemid 29077390)
42. Tak PP, Bacchi M, Bertolino M (2006) Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur J Drug Metab Pharmacokinet 31: 109-116. (Pubitemid 44166289)
43. Veenbergen S, Smeets R, Bennink M, Arntz O, Joosten L, et al. (2010) The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses. Ann Rheum Dis 69: 276-283.